Jan Liliemark
- Genetics top 0.5%
- Molecular Biology top 10%
- Oncology top 2%
- Public Health, Environmental and Occupational Health top 2%
- Pathology and Forensic Medicine top 1%
- Co-authors
- Gunnar JuliussonWilliam PlunkettFreidoun AlbertioniCurt PetersonElihu H. EsteyMichael J. KeatingRodiça LenkeiAnnika Elmhorn‐Rosenborg
- Topics
- Chronic Lymphocytic Leukemia Research (48 papers)Acute Lymphoblastic Leukemia research (35 papers)Lymphoma Diagnosis and Treatment (22 papers)
- Partner nations
- SwedenUnited StatesAustralia
In The Last Decade
Jan Liliemark
112 papers receiving 3.1k citations
Peers
Comparison fields: 5 of 102
- Genetics 1.5k
- Molecular Biology 998
- Oncology 992
- Public Health, Environmental and Occupational Health 896
- Pathology and Forensic Medicine 855
Countries citing papers authored by Jan Liliemark
This map shows the geographic impact of Jan Liliemark's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Liliemark with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Liliemark more than expected).
Fields of papers citing papers by Jan Liliemark
This network shows the impact of papers produced by Jan Liliemark. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Liliemark. The network helps show where Jan Liliemark may publish in the future.
Co-authorship network of co-authors of Jan Liliemark
This figure shows the co-authorship network connecting the top 25 collaborators of Jan Liliemark. A scholar is included among the top collaborators of Jan Liliemark based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan Liliemark. Jan Liliemark is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 8 | |
| 3 | [The willingness to pay for new drugs is based on ethical principles]. | 1 |
| 4 | 13 | |
| 5 | 13 | |
| 6 | 32 | |
| 7 | 24 | |
| 8 | 13 | |
| 9 | 7 | |
| 10 | 12 | |
| 11 | 68 | |
| 12 | 10 | |
| 13 | 28 | |
| 14 | 29 | |
| 15 | 10 | |
| 16 | 32 | |
| 17 | 20 | |
| 18 | 6 | |
| 19 | 43 | |
| 20 | 7 |
About Jan Liliemark
Jan Liliemark is a scholar working on Genetics, Hematology and Oncology, having authored 113 papers that have together received 3.2k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (48 papers), Acute Lymphoblastic Leukemia research (35 papers) and Lymphoma Diagnosis and Treatment (22 papers). The work is most often cited by research in Genetics (1.5k citations), Hematology (792 citations) and Pathology and Forensic Medicine (855 citations). Jan Liliemark has collaborated with scholars based in Sweden, United States and Australia. Frequent co-authors include Gunnar Juliusson, William Plunkett, Freidoun Albertioni, Curt Peterson, Elihu H. Estey, Michael J. Keating, Rodiça Lenkei, Annika Elmhorn‐Rosenborg, Birgitta Pettersson and Christer Paul. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.